These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28711476)

  • 1. Treatment in early psychosis with N-acetyl-cysteine for 6months improves low-level auditory processing: Pilot study.
    Retsa C; Knebel JF; Geiser E; Ferrari C; Jenni R; Fournier M; Alameda L; Baumann PS; Clarke S; Conus P; Do KQ; Murray MM
    Schizophr Res; 2018 Jan; 191():80-86. PubMed ID: 28711476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
    Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of glycine on auditory mismatch negativity in schizophrenia.
    Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
    Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
    Geiser E; Retsa C; Knebel JF; Ferrari C; Jenni R; Fournier M; Alameda L; Baumann PS; Clarke S; Conus P; Do KQ; Murray MM
    Schizophr Res; 2017 Dec; 190():52-59. PubMed ID: 28189532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
    Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
    Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial.
    Klauser P; Xin L; Fournier M; Griffa A; Cleusix M; Jenni R; Cuenod M; Gruetter R; Hagmann P; Conus P; Baumann PS; Do KQ
    Transl Psychiatry; 2018 Oct; 8(1):220. PubMed ID: 30315150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NMDA receptor antagonist memantine on mismatch negativity.
    Korostenskaja M; Nikulin VV; Kicić D; Nikulina AV; Kähkönen S
    Brain Res Bull; 2007 May; 72(4-6):275-83. PubMed ID: 17452287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis.
    Hamilton HK; Roach BJ; Bachman PM; Belger A; Carrión RE; Duncan E; Johannesen JK; Light GA; Niznikiewicz MA; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Cannon TD; Mathalon DH
    JAMA Psychiatry; 2022 Aug; 79(8):780-789. PubMed ID: 35675082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study.
    Mullier E; Roine T; Griffa A; Xin L; Baumann PS; Klauser P; Cleusix M; Jenni R; Alemàn-Gómez Y; Gruetter R; Conus P; Do KQ; Hagmann P
    Int J Neuropsychopharmacol; 2019 Aug; 22(8):478-487. PubMed ID: 31283822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
    Conus P; Seidman LJ; Fournier M; Xin L; Cleusix M; Baumann PS; Ferrari C; Cousins A; Alameda L; Gholam-Rezaee M; Golay P; Jenni R; Woo TW; Keshavan MS; Eap CB; Wojcik J; Cuenod M; Buclin T; Gruetter R; Do KQ
    Schizophr Bull; 2018 Feb; 44(2):317-327. PubMed ID: 29462456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.
    Horton J; Millar A; Labelle A; Knott VJ
    Schizophr Res; 2011 Mar; 126(1-3):202-11. PubMed ID: 21194893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Rapado-Castro M; Dodd S; Bush AI; Malhi GS; Skvarc DR; On ZX; Berk M; Dean OM
    Psychol Med; 2017 Apr; 47(5):866-876. PubMed ID: 27894373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal prevention of first psychotic episode through N-acetyl-l-cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo-controlled, parallel-group trial.
    Schmidt SJ; Hurlemann R; Schultz J; Wasserthal S; Kloss C; Maier W; Meyer-Lindenberg A; Hellmich M; Muthesius-Digón A; Pantel T; Wiesner PS; Klosterkötter J; Ruhrmann S;
    Early Interv Psychiatry; 2019 Dec; 13(6):1404-1415. PubMed ID: 30784233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders.
    Breier A; Liffick E; Hummer TA; Vohs JL; Yang Z; Mehdiyoun NF; Visco AC; Metzler E; Zhang Y; Francis MM
    Schizophr Res; 2018 Sep; 199():395-402. PubMed ID: 29588126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
    Leung S; Croft RJ; Baldeweg T; Nathan PJ
    Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Auditory event-related potential of subjects with suspected pre-psychotic state and first-episode psychosis.
    Hsieh MH; Shan JC; Huang WL; Cheng WC; Chiu MJ; Jaw FS; Hwu HG; Liu CC
    Schizophr Res; 2012 Sep; 140(1-3):243-9. PubMed ID: 22784684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of auditory information-processing deficits in schizophrenia.
    Turetsky BI; Bilker WB; Siegel SJ; Kohler CG; Gur RE
    Psychiatry Res; 2009 Jan; 165(1-2):27-37. PubMed ID: 18990453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.